enVVeno Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
enVVeno Medical Corp (NVNO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 33.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-30
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 17.14M shares.
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 33.00K shares, a 5.71% decline from fiscal 2024.
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 35.00K shares, a 96.59% decline from fiscal 2023.
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.03M shares, a 148.16% increase from fiscal 2022.
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 413.61K shares, a 99.99% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 33.00K shares 10-K · filed 2026-03-26 | |||
| 2025-06-30 | 17.14M shares 10-Q · filed 2026-07-30 | 17.14M shares 10-Q · filed 2026-07-30 | ||
| 2024-12-31 | 35.00K shares 10-K · filed 2026-03-26 | 1.21M shares 10-K · filed 2025-02-28 | ||
| 2023-12-31 | 1.03M shares 10-K · filed 2025-02-28 | |||
| 2022-12-31 | 413.61K shares 10-K · filed 2024-02-29 | 413.61M shares 10-K · filed 2023-03-02 | ||
| 2021-12-31 | 3.25B shares 10-K · filed 2023-03-02 | 3.25M shares 10-K · filed 2022-03-28 | ||
| 2020-12-31 | 122.00K shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |